Perindopril erbumine 4mg/5ml oral suspension
BNF presentation 0205051M0AAALAL within chapter Cardiovascular System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0205051M0AAALAL
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
36
NHS spend (£)
£1,081.41
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 3 |
| December 2024 | 3 |
| November 2024 | 4 |
| October 2024 | 5 |
| August 2024 | 1 |
| July 2024 | 10 |
| May 2024 | 1 |
| July 2021 | 1 |
| December 2020 | 2 |
| November 2020 | 6 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
|
Bosvena Health
ODS L82010
|
3 | 11N - CORNWALL & THE ISLES OF SCILLY ICB |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 1 | No data available |
| Unknown pharmacy | 1 | No data available |
| Unknown pharmacy | 1 | No data available |